OSELTAMIVIR PHOSPHATE

Exelan Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Sep 1, 2023
Approval ID: 31c90a2e-9d14-4236-8dc2-b2a862e8cbac
Products: 3 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use OSELTAMIVIR PHOSPHATE CAPSULES safely and effectively. See full prescribing information for OSELTAMIVIR PHOSPHATE CAPSULES. OSELTAMIVIR PHOSPHATE capsules, for oral useInitial U.S. Approval: 1999

Quick Stats

Total Products3

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.